Yibei Zhu
MOE Key Laboratory Of Geriatric Diseases And Immunology
Suzhou, China
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies.
Journal: Frontiers in immunology
Published: August 20, 2022
Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
Journal: Journal of neuroimmunology
Published: May 04, 2022
PD-1 blockade combined with IL-33 enhances the antitumor immune response in a type-1 lymphocyte-mediated manner.
Journal: Cancer treatment and research communications
Published: April 13, 2021
Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells.
Journal: Frontiers in cell and developmental biology
Published: December 10, 2020
Fertility preservation in BRCA mutation carriers-efficacy and safety issues: a review.
Journal: Reproductive biology and endocrinology : RB&E
Published: November 14, 2019
Association between interleukin-36γ and tumor progression in non-small cell lung cancer.
Journal: Oncology letters
Published: July 25, 2019
IL-36β Promotes CD8+ T Cell Activation and Antitumor Immune Responses by Activating mTORC1.
Journal: Frontiers in immunology
Published: May 03, 2019
Interleukin-33, a Potential Cytokine Expressed in Tumor Microenvironment Involves in Antitumor Immunotherapy Through Facilitates CD8+ T Cells.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: November 20, 2018
MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma.
Journal: Molecular pharmaceutics
Published: June 16, 2018
Last Updated: 09/26/2026